Stock Code: 002772 stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022-004 bond Code: 128026 bond abbreviation: Zhongxing convertible bond
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Announcement on by election of independent directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Ms. Peng Ling, the former independent director of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”), applied for resignation from the position of independent director of the Fourth Board of directors, member of the strategy committee of the board of directors and chairman of the remuneration and assessment committee of the board of directors for personal reasons. Ms. Peng Ling’s resignation will take effect after the new independent director is elected at the general meeting of the company, For details, please refer to securities times, Shanghai Securities News and cninfo.com published by the company on December 25, 2021（ http://www.cn.info.com.cn. ）Announcement on resignation of independent directors (Announcement No.: 2021-131).
On January 12, 2022, the company held the 10th meeting of the 4th board of directors, deliberated and adopted the proposal on by election of independent director candidates of the 4th board of directors. After the qualification review of the nomination committee of the board of directors, the board of directors plans to nominate Ms. danglin as the independent director candidate of the 4th board of directors of the company (see Annex for resume), The term of office starts from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the Fourth Board of directors.
After being elected as an independent director of the company with the consent of the general meeting of shareholders, Ms. danglin will also serve as a member of the strategy committee of the board of directors and the chairman of the remuneration and assessment committee of the board of directors. Her term of office starts from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the term of office of the Fourth Board of directors.
The independent directors of the company expressed their independent opinions on the matter. After the election is passed, the number of independent directors in the Fourth Board of directors of the company shall not be less than one-third of the members of the board of directors, and there is no situation that the term of office of independent directors of the company is more than six years; The total number of directors who concurrently hold the position of senior management of the company in the board of directors shall not exceed one-half of the total number of directors of the company, meeting the requirements of relevant laws and regulations.
Ms. Dang Lin has obtained the qualification certificate of independent director. The qualification and independence of independent director candidates shall be reviewed by Shenzhen Stock Exchange before they can be submitted to the general meeting of shareholders for deliberation.
It is hereby announced
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) board of directors January 12, 2022
enclosure:
Resume of Ms. Dang Lin
Dang Lin: female, born in August 1975, Han nationality, Chinese nationality, bachelor degree. He is now a partner lawyer of Shanghai Huiye (Lanzhou) law firm, an independent director of Gansu ronghua industry (Group) Co., Ltd., and intends to be an independent director of the company. He was a practicing lawyer in the financial and securities business department of Gansu zhengtianhe law firm. Up to now, Ms. Dang Lin has no shares in the company and has no relationship with shareholders holding more than 5% of the company, actual controllers, other directors, supervisors and senior managers of the company. Ms. Dang Lin has not been punished by China Securities Regulatory Commission and other relevant departments or by the stock exchange. She is not a person subject to dishonesty. Her qualifications meet the relevant provisions of the company law and the articles of association, There are no circumstances specified in Article 146 of the company law and article 3.2.2 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board.
